Posted on Leave a comment

The 27 SEA biotech firms betting on cells, fermentation, and code

Southeast Asia’s startup story is usually told through ride-hailing, fintech, and e-commerce. But a quieter, stranger, and potentially more consequential sector is taking shape in the region’s labs, farms, and hospitals: biotech.

Founders are using fermentation to turn waste into biomaterials, growing seafood and fat from cells, building AI tools for cancer care and heart scans, engineering crops for tougher climates, and developing diagnostics designed specifically for Asian populations. It is not an easy sector to build in; biotech demands patient capital, deep technical talent, complex regulatory navigation, and long commercialisation cycles.

Also Read: Asia’s biotech boom: Innovation, investment, and a new era of discovery

Yet the sheer breadth of companies now emerging from Singapore, Malaysia, Indonesia, Thailand, Vietnam, and the Philippines suggests the region’s life-sciences ecosystem has moved well past the experimental stage, and is beginning to challenge assumptions about where deeptech gets built.

Below is a list of 27 biotech firms that are redrawing the region innovation map:

RWDC Industries (Singapore)

RWDC ferments used cooking oil into PHA, a fully biodegradable biopolymer that’s meant to replace single-use plastic in straws, cutlery and packaging.

Founders Founding year Funding Investors
Roland Wee and Dr Daniel Carraway 2015 Series A (2018, 2019) and a headline-grabbing US$133 million Series B (2020) Vickers Venture Partners, WI Harper Group, and Temasek

Protenga (Singapore/Malaysia)

Protenga runs “Smart Insect Farms” that turn organic waste into black soldier fly protein for aquaculture, animal feed and pet food.

Founders Founding year Funding Investors
Leo Wein 2016 Seed round, 2020 SEEDS Capital, Roslin Technologies

Engine Biosciences (Singapore/US)

Engine Biosciences combines AI with wet-lab biology to map gene interactions and speed up cancer drug discovery.

Founders Founding year Funding Investors
Jeffrey Lu, Timothy Lu, Daphne Teo, 2015 US$10 million seed (2018), Southeast Asia’s largest institutional seed round at the time, followed by Series A (2021) 6 Dimensions Capital, DHVC

Us2.ai (Singapore)

Us2.ai uses AI to automate the reading of echocardiograms, cutting a process that takes cardiologists many minutes down to under two.
Founders: James Hare, Dr Carolyn Lam, Dr Yoran Hummel and Paul Seekings

Founders Founding year Funding Investors
James Hare, Dr Carolyn Lam, Dr Yoran Hummel and Paul Seekings 2017 Pre-seed (2019) and Series A of US$16 million (2022) Sequoia Capital and EDBI

AMILI (Singapore)

AMILI runs Southeast Asia’s first gut microbiome bank, building an Asia-specific database to power diagnostics and personalised nutrition.

Founders Founding year Funding Investors
Dr Jeremy Lim and Dr Jonathan Lee 2019 Series A, US$10.5 million (2022) Vulcan Capital, SEEDS Capital, and Emtek Group

KYAN Technologies (Singapore)

KYAN applies “small data AI” to match cancer patients with the most effective drug-dose combinations, developed with NUS and UCLA.

Founders Founding year Funding Investors
Dean Ho and Chih-Ming Ho 2016 Seed round (2022) and a subsequent pre-Series A Undisclosed

ImpacFat (Singapore)

ImpacFat cultivates omega-3-rich fish fat from stem cells, aimed at alt-meat, cosmetics and supplements.

Founders Founding year Funding Investors
Mandy Hon and Dr Shigeki Sugii 2019 Pre-seed round, 2022 Big Idea Ventures

Qarbotech (Malaysia)

Qarbotech makes QarboGrow, a carbon-quantum-dot photosynthesis enhancer that boosts crop yields without genetic modification.

Founders Founding year Funding Investors
Chor Chee Hoe, Prof Suraya Abdul Rashid and Amirul Merican 2018 Seed round, US$700,000 (2023) Khazanah Nasional, Temasek Holdings, 500 Global

NLYTech Biotech (Malaysia)

NLYTech develops biodegradable, plastic-free packaging materials made from natural ingredients as an alternative to single-use plastics.

Founders Founding year Funding Investors
Yee Tee Law 2019-20 Seed round, 2020 Undisclosed

Vulcan Augmetics (Vietnam)

Vulcan builds affordable, modular robotic prosthetics designed to click together like building blocks.

Founders Founding year Funding Investors
Rafael Masters 2019 Pre-seed/angel round, 2019 Undisclosed

Teora (Singapore)

Teora develops biologics that manage disease in agriculture and aquaculture without relying on chemical pesticides.

Founders Founding year Funding Investors
Rishita Changede 2020 Seed round, 2022 Entrepreneur First, Plug and Play APAC, Investible

KINNVA (Singapore)

KINNVA is a synthetic-biology company using fermentation to turn waste streams into biochemicals for food, feed and cosmetics.

Founders Founding year Funding Investors
Brian Reddy 2019 Pre-seed round, 2019 Hatch Singapore

Sinhke (Vietnam)

Sinhke builds AI-powered hardware that measures shrimp larvae health before farmers commit to large-scale cultivation.

Founders Founding year Funding Investors
Ngoc Phuong Hoang Nguyen 2024 Pre-seed round, 2024 Antler

Virdalis (Singapore)

Virdalis is building a cultivation and data platform around duckweed, the world’s fastest-growing flowering plant, as a soy alternative for animal feed protein.

Founders Founding year Funding Investors
JM Aujero 2025-26 Pre-seed round, early 2026 Undisclosed

Allozymes (Singapore)

Allozymes runs an ultra-high-throughput microfluidics platform that screens millions of enzyme variants a day, effectively an “enzyme discovery engine” for pharma, food and chemical industries.

Founders Founding year Funding Investors
Peyman Salehian and Dr Akbar Vahidi 2019-2020 as an NUS spin-out Seed (2019) and a US$15 million Series A (2024) SOSV, Entrepreneur First, Seventure Partners, Xora Innovation

FathomX (Singapore)

FathomX is an NUS/NUHS spin-off building AI to improve the accuracy of mammograms, particularly for dense breast tissue common among Asian women.

Founders Founding year Funding Investors
Prof Mikael Hartman and Prof Mengling Feng (CEO: Stephen Lim) 2019 Pre-Series A, SGD2.24 million (2022) Undisclosed; backed by SMART, NHIC, Enterprise Singapore programmes

REVIVO BioSystems (Singapore)

An A*STAR spin-off building “organ-on-a-chip” 4D human skin models to replace animal testing for cosmetics and pharma compounds.

Founders Founding year Funding Investors
Dr Massimo Alberti and Bert Grobben 2019 Seed round, 2020 Evonik Venture Capital

Advanx Health (Malaysia)

Malaysia’s first consumer DNA-testing company, offering genetic reports on health risk, nutrition and fitness traits.

Founders Founding year Funding Investors
Yong Wei Shian and Chew Yen Ping 2017 Angel/pre-seed round, 2018 Undisclosed

KosmodeHealth (Singapore)

An NUS Food Science spin-off extracting proteins and fibres from food-processing waste to formulate functional foods and biomedical bio-ink.

Founders Founding year Funding Investors
Florence Leong and an NUS Food Science & Technology professor (co-founder) 2019 Angel/pre-seed round, 2019 Rapzo Capital, NUS, BLOCK71

Imagene Labs (Singapore)

A subsidiary of Asia Genomics offering saliva-based DNA testing for personalised nutrition, skincare and fitness products across Asia.

Founders Founding year Funding Investors
Dr Mun Yew Wong 2016 Series A (undisclosed amount) Formation 8

Meatiply (Singapore)

Meatiply is a multi-cell-type cultivated meat company that produced Asia’s first cultivated smoked duck breast.

Founders Founding year Funding Investors
Dr Elwin Tan, Dr Benjamin Chua, Dr Jason Chua and Prof Teh Bin Tean 2021 Pre-seed (2022) and US$3.75 million seed round (2023) Wavemaker Partners, AgFunder, SEEDS Capital

Singrow (Singapore)

An agri-biotech firm that cross-bred and gene-edited the world’s first tropical-climate strawberry, grown in an indoor vertical farm.

Founders Founding year Funding Investors
Dr Bao Shengjie and Xu Tao 2019 Seed round and a US$4.5 million Series A (2025) AgFunder

Dendrotonics (Philippines)

Develops biodiversity-restoration technology to make degraded land ecologically and commercially productive again.

Founders Founding year Funding Investors
Ephraim Cercado 2023 Pre-Series A/Bridge round, 2023 Undisclosed

QuikPath (Singapore)

Built a self-administered RT-PCR Covid-19 screening technology designed to scale rapid, accurate infection monitoring.

Founders Founding year Funding Investors
Janelle Ang 2020 Angel/pre-seed round, 2020 Undisclosed

ETBio (Singapore)

Harnesses microalgae to build next-generation air filtration solutions.

Founders Founding year Funding Investors
Blaz Bakalar 2019 Angel/pre-seed round, 2019 Undisclosed

Ternion Biosciences (Singapore)

Provides high-throughput cardiac safety screening assays used in preclinical drug development.

Founders Founding year Funding Investors
Poh Loong Soong 2017 Angel/pre-seed round, 2017 Undisclosed

CloudSeq (Singapore)

CloudSeq runs an NRF-backed cloud platform built to handle big data for healthcare and agricultural genomics.

Founders Founding year Funding Investors
Dadabhai T. Singh 2016 Seed round, 2016 National Research Foundation Singapore (grant-backed)

The post The 27 SEA biotech firms betting on cells, fermentation, and code appeared first on e27.

Leave a Reply

Your email address will not be published. Required fields are marked *